|
Summary Information: Pharvaris N.V. Ordinary Shares NASDAQ:PHVS |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.
__The following are links to various summary and news pages for __Pharvaris N.V. Ordinary Shares [ PHVS ]. __Note: Some Links might not have information for the company. |
|